Abstract:There have been ongoing debates about resuscitation fluids because each of the current fluids has its own disadvantages. The debates essentially reflect an embarrassing clinical status quo that all fluids are not quite ideal in most clinical settings. Therefore, a novel fluid that overcomes the limitations of most fluids is necessary for most patients, particularly diabetic and older patients. Pyruvate is a natural potent antioxidant/nitrosative and anti-inflammatory agent. Exogenous pyruvate as an alkalizer can increase cellular hypoxia and anoxia tolerance with the preservation of classic glycolytic pathways and the reactivation of pyruvate dehydrogenase activity to promote oxidative metabolism and reverse the Warburg effect, robustly preventing and treating hypoxic lactic acidosis, which is one of the fatal complications in critically ill patients. In animal studies and clinical reports, pyruvate has been shown to play a protective role in multi-organ functions, especially the heart, brain, kidney, and intestine, demonstrating a great potential to improve patient survival. Pyruvate-enriched fluids including crystalloids and colloids and oral rehydration solution (ORS) may be ideal due to the unique beneficial properties of pyruvate relative to anions in contemporary existing fluids, such as acetate, bicarbonate, chloride, citrate, lactate, and even malate. Preclinical studies have demonstrated that pyruvate-enriched saline is superior to 0.9% sodium chloride. Moreover, pyruvate-enriched Ringer's solution is advantageous over lactated Ringer's solution. Furthermore, pyruvate as a carrier in colloids, such as hydroxyethyl starch 130/0.4, is more beneficial than its commercial counterparts. Similarly, pyruvate-enriched ORS is more favorable than WHO-ORS in organ protection and shock resuscitation. It is critical that pay attention first to improving abnormal saline with pyruvate for ICU patients. Many clinical trials with a high dose of intravenous or oral pyruvate were conducted over the past half century, and results indicated its effectiveness and safety in humans. The long-term instability of pyruvate aqueous solutions and para-pyruvate cytotoxicity is not a barrier to the pharmaceutical manufacturing of pyruvate-enriched fluids for ICU patients. Clinical trials with sodium pyruvate-enriched solutions are urgently warranted.

Evogenous Ethyl Pyruvate Versus Pyruvate During Metabolic Recovery After Oxidative Stress In Neonatal Rat Cerebroconical Slices

Antioxidant Effect of Ethyl Pyruvate in Respiring Neonatal Cerebrocortical Slices after H2O2 Stress

Pyruvate improves recovery after PARP-1-associated energy failure induced by oxidative stress in neonatal rat cerebrocortical slices.

Ethyl Pyruvate Protects Against Hypoxic-Ischemic Brain Injury Via Anti-Cell Death and Anti-Inflammatory Mechanisms

Erythropoietin Protects Primary Cultures of Rat Cortical Neurons from Hypoxia-Induced Toxicity Through Attenuating Both Glutamate Release and NMDA Receptor Evoked Neurotoxicity Pathway.

Protective Effect of Ethyl Pyruvate on Brain Tissues in Neonatal Rats with Hypoxic-Ischemic Brain Damage

Ethyl Pyruvate Reduces Myocardial Ischemia and Reperfusion Injury by Inhibiting High Mobility Group Box 1 Protein in Rats

Mechanism of Protection of Ethyl Pyruvate against Oxidative Stress Injury in Hepatocytes

Ethyl pyruvate, a potentially effective mitigator of damage after total-body irradiation.

Pyruvate improves cerebral metabolism during hemorrhagic shock

Effects of Augmented Delivery of Pyruvate on Myocardial High-Energy Phosphate Metabolism at High Workstate

Ethyl Pyruvate Protects Against Experimental Acute-On-Chronic Liver Failure in Rats

Ethyl Pyruvate Protects Against Blood-Brain Barrier Damage and Improves Long-Term Neurological Outcomes in a Rat Model of Traumatic Brain Injury.

Pyruvate alleviates lipid peroxidation and multiple-organ dysfunction in rats with hemorrhagic shock

Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury By Inhibiting Intrinsic Pathway Of Apoptosis And Autophagy (Vol 2013, 461536, 2013)

Pyruvate is superior to reverse visceral hypoperfusion in peritoneal resuscitation from hemorrhagic shock in rats

Protective effect of Ethyl Pyruvate on ischemic/reperfusion renal injury and ischemic HK-2 cells in mice

Oral pyruvate prevents high-intensity interval exercise-induced metabolic acidosis in rats by promoting lactate dehydrogenase reaction

Ethyl pyruvate: A newly discovered compound against ischemia-reperfusion injury in multiple organs

Pyruvate as a Potential Beneficial Anion in Resuscitation Fluids

Metabolic-driven analytics of traumatic brain injury and neuroprotection by ethyl pyruvate